Hureau, M.; Portier, L.; Prin, M.; de Nadai, P.; Balsamelli, J.; Tsicopoulos, A.; Mathieu, D.; Lassalle, P.; Grigoriu, B.; Gaudet, A.;
et al. Evaluation of Endocan as a Treatment for Acute Inflammatory Respiratory Failure. Cells 2023, 12, 257.
https://doi.org/10.3390/cells12020257
AMA Style
Hureau M, Portier L, Prin M, de Nadai P, Balsamelli J, Tsicopoulos A, Mathieu D, Lassalle P, Grigoriu B, Gaudet A,
et al. Evaluation of Endocan as a Treatment for Acute Inflammatory Respiratory Failure. Cells. 2023; 12(2):257.
https://doi.org/10.3390/cells12020257
Chicago/Turabian Style
Hureau, Maxence, Lucie Portier, Méline Prin, Patricia de Nadai, Joanne Balsamelli, Anne Tsicopoulos, Daniel Mathieu, Philippe Lassalle, Bogdan Grigoriu, Alexandre Gaudet,
and et al. 2023. "Evaluation of Endocan as a Treatment for Acute Inflammatory Respiratory Failure" Cells 12, no. 2: 257.
https://doi.org/10.3390/cells12020257
APA Style
Hureau, M., Portier, L., Prin, M., de Nadai, P., Balsamelli, J., Tsicopoulos, A., Mathieu, D., Lassalle, P., Grigoriu, B., Gaudet, A., & De Freitas Caires, N.
(2023). Evaluation of Endocan as a Treatment for Acute Inflammatory Respiratory Failure. Cells, 12(2), 257.
https://doi.org/10.3390/cells12020257